Skip to main content
. 2020 Nov 6;11(12):2510–2518. doi: 10.1021/acsmedchemlett.0c00496

Table 5. Exposure of Compound 18 following Dosing Prodrug 19 in Mouse Acanthosis.

dose (mg/kg QD)a 5 15 45
day 1 AUCtot (μM-h) 13.9 30.9 274.3
day 9 AUC24 (μM-h) 9.0 45.2 162.9
day 9 Cmax (μM) 0.65 ± 0.19 2.58 ± 0.36 8.34 ± 2.26
day 1 C24h (μM) 0.21 ± 0.08 0.48 ± 0.14 0.91 ± 0.33
day 9 C24h (μM) 0.15 ± 0.08 1.36 ± 0.56 5.82 ± 1.10
day 9 C24h fold mouse Th17 IC90b 0.4× 3.2× 13.9×
a

Prodrug was dosed to provide the indicated amount of parent after phosphate hydrolysis; solution vehicle: 20% of 0.1 M acetate buffer; 80% PEG 400.

b

Protein binding adjusted mouse Th17 IC90 = 0.42 μM